Grifols, Barcelona, and Beckman Coulter Inc, Brea, Calif, have entered into an exclusive, long-term agreement for the global distribution of Grifols’ hemostasis instruments, reagents, and consumables.
Carsten Schroeder, Grifols.
“Grifols continues to execute its strategy in growing the specialty diagnostics line,” says Carsten Schroeder, president of diagnostic commercial operations at Grifols. “Our hemostasis product line complements Beckman Coulter’s broad portfolio of products and services for the core laboratory.”
Arnd Kaldowski, Beckman Coulter Diagnostics.
“Beckman Coulter’s long-term partnership with Grifols expands our extensive diagnostic product offering and further supports our position as a partner of choice with hospitals and clinical laboratories across the world,” says Arnd Kaldowski, president of Beckman Coulter Diagnostics.
Beckman Coulter and Grifols anticipate first commercializing systems under this distribution agreement in Europe in early 2018.
Oriol Duñach, Grifols.
“We are extremely excited about the collaboration with Beckman Coulter,” adds Oriol Duñach, president of the diagnostic industrial division at Grifols. “The agreement leverages Grifols’ strength in manufacturing reliable instruments and reagents with that of Beckman Coulter’s commercial strength.”
For more information, visit Beckman Coulter or Grifols.
